Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXCM DexCom	$65.33 -1.3%	$74.01	$57.52 ▼ $93.25	$25.57B	1.47	4.21 million shs	2.08 million shs
GMED Globus Medical	$58.38 +0.5%	$58.94	$51.79 ▼ $94.93	$7.88B	1.12	1.41 million shs	608,064 shs
PODD Insulet	$312.35 -1.9%	$325.03	$226.50 ▼ $353.50	$22.02B	1.4	734,624 shs	220,916 shs
STE STERIS	$236.42 -0.6%	$244.75	$200.98 ▼ $253.00	$23.28B	1.01	585,477 shs	197,832 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXCM DexCom	+1.55%	+0.27%	-13.13%	-21.30%	-4.29%
GMED Globus Medical	+0.87%	-2.23%	-1.19%	+2.57%	-18.44%
PODD Insulet	+1.19%	+1.55%	-6.87%	+10.42%	+36.90%
STE STERIS	+0.96%	-1.52%	-4.86%	+4.59%	+4.25%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXCM DexCom	$65.33 -1.3%	$74.01	$57.52 ▼ $93.25	$25.57B	1.47	4.21 million shs	2.08 million shs
GMED Globus Medical	$58.38 +0.5%	$58.94	$51.79 ▼ $94.93	$7.88B	1.12	1.41 million shs	608,064 shs
PODD Insulet	$312.35 -1.9%	$325.03	$226.50 ▼ $353.50	$22.02B	1.4	734,624 shs	220,916 shs
STE STERIS	$236.42 -0.6%	$244.75	$200.98 ▼ $253.00	$23.28B	1.01	585,477 shs	197,832 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXCM DexCom	+1.55%	+0.27%	-13.13%	-21.30%	-4.29%
GMED Globus Medical	+0.87%	-2.23%	-1.19%	+2.57%	-18.44%
PODD Insulet	+1.19%	+1.55%	-6.87%	+10.42%	+36.90%
STE STERIS	+0.96%	-1.52%	-4.86%	+4.59%	+4.25%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXCM DexCom	2.87	Moderate Buy	$97.00	48.47% Upside
GMED Globus Medical	2.57	Moderate Buy	$87.27	49.49% Upside
PODD Insulet	2.86	Moderate Buy	$348.05	11.43% Upside
STE STERIS	2.78	Moderate Buy	$273.50	15.68% Upside

Current Analyst Ratings Breakdown

Latest GMED, DXCM, STE, and PODD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2025	DXCM DexCom	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$102.00 ➝ $94.00
10/14/2025	PODD Insulet	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$339.00 ➝ $355.00
10/14/2025	STE STERIS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B)
10/10/2025	GMED Globus Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$88.00
10/10/2025	PODD Insulet	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$350.00 ➝ $365.00
10/8/2025	DXCM DexCom	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C-)
10/8/2025	GMED Globus Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
10/8/2025	PODD Insulet	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
10/7/2025	DXCM DexCom	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$105.00 ➝ $85.00
10/3/2025	PODD Insulet	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$350.00 ➝ $370.00
10/1/2025	DXCM DexCom	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$104.00 ➝ $89.00

(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXCM DexCom	$4.30B	5.96	$2.25 per share	29.01	$5.38 per share	12.14
GMED Globus Medical	$2.52B	3.13	$6.76 per share	8.63	$30.40 per share	1.92
PODD Insulet	$2.07B	10.61	$4.41 per share	70.90	$17.27 per share	18.09
STE STERIS	$5.57B	4.18	$14.31 per share	16.52	$67.33 per share	3.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXCM DexCom	$576.20M	$1.44	45.28	26.56	1.37	13.29%	30.41%	10.08%	10/30/2025 (Confirmed)
GMED Globus Medical	$102.98M	$2.60	22.45	14.49	1.57	13.58%	10.65%	8.86%	11/4/2025 (Estimated)
PODD Insulet	$418.30M	$3.29	95.10	62.85	2.63	10.01%	23.78%	9.30%	11/6/2025 (Estimated)
STE STERIS	$614.64M	$6.53	36.20	23.81	N/A	11.61%	14.17%	9.25%	11/5/2025 (Estimated)

Latest GMED, DXCM, STE, and PODD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/6/2025	Q3 2025	PODD Insulet	$1.15	N/A	N/A	N/A	$678.70 million	N/A
11/5/2025	Q2 2026	STE STERIS	$2.37	N/A	N/A	N/A	$1.43 billion	N/A
11/4/2025	Q3 2025	GMED Globus Medical	$0.79	N/A	N/A	N/A	$734.58 million	N/A
10/30/2025	Q3 2025	DXCM DexCom	$0.57	N/A	N/A	N/A	$1.18 billion	N/A
8/7/2025	Q2 2025	GMED Globus Medical	$0.76	$0.86	+$0.10	$1.50	$738.91 million	$745.34 million
8/7/2025	Q2 2025	PODD Insulet	$0.92	$1.17	+$0.25	$0.32	$612.31 million	$649.10 million
8/6/2025	Q1 2026	STE STERIS	$2.32	$2.34	+$0.02	$1.79	$1.36 billion	$1.40 billion
7/30/2025	Q2 2025	DXCM DexCom	$0.45	$0.48	+$0.03	$0.45	$1.13 billion	$1.16 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXCM DexCom	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.52	1.07%	N/A	38.59%	20 Years

Latest GMED, DXCM, STE, and PODD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2025	STE STERIS	quarterly	$0.63	1.04%	9/4/2025	9/4/2025	9/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXCM DexCom	0.48	1.52	1.35
GMED Globus Medical	N/A	4.07	2.26
PODD Insulet	0.64	2.26	1.81
STE STERIS	0.27	2.22	1.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DXCM DexCom	97.75%
GMED Globus Medical	95.16%
PODD Insulet	N/A
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
DXCM DexCom	0.32%
GMED Globus Medical	18.54%
PODD Insulet	0.39%
STE STERIS	1.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DXCM DexCom	10,300	392.16 million	390.90 million	Optionable
GMED Globus Medical	5,300	135.06 million	110.02 million	Optionable
PODD Insulet	3,900	70.39 million	70.12 million	Optionable
STE STERIS	17,787	98.49 million	97.44 million	Optionable

GMED, DXCM, STE, and PODD Headlines

Recent News About These Companies

Equitable Trust Co. Decreases Position in STERIS plc $STE

October 15 at 5:19 AM | marketbeat.com

Sequoia Financial Advisors LLC Buys 1,397 Shares of STERIS plc $STE

October 15 at 4:25 AM | marketbeat.com

Aberdeen Group plc Has $19.10 Million Position in STERIS plc $STE

October 15 at 3:42 AM | marketbeat.com

Callan Family Office LLC Makes New Investment in STERIS plc $STE

October 15 at 3:33 AM | marketbeat.com

Steris PLC

October 14 at 6:43 PM | wsj.com

STERIS (NYSE:STE) Receives Buy (B) Rating from Weiss Ratings

October 14 at 1:22 PM | marketbeat.com

Boston Trust Walden Corp Acquires 67,709 Shares of STERIS plc $STE

October 14 at 7:22 AM | marketbeat.com

STERIS plc $STE Shares Sold by Wilmington Savings Fund Society FSB

October 14 at 7:06 AM | marketbeat.com

US Bancorp DE Sells 8,482 Shares of STERIS plc $STE

October 14 at 3:43 AM | marketbeat.com

2,016 Shares in STERIS plc $STE Acquired by DAVENPORT & Co LLC

October 13 at 3:15 AM | marketbeat.com

Inspire Investing LLC Purchases 3,748 Shares of STERIS plc $STE

October 11, 2025 | marketbeat.com

STERIS plc $STE Stock Position Decreased by Villere ST Denis J & Co. LLC

October 11, 2025 | marketbeat.com

1,375 Shares in STERIS plc $STE Bought by Valmark Advisers Inc.

October 11, 2025 | marketbeat.com

STERIS plc $STE Shares Acquired by KLP Kapitalforvaltning AS

October 10, 2025 | marketbeat.com

STERIS (NYSE:STE) CEO Daniel Carestio Sells 159 Shares

October 9, 2025 | marketbeat.com

STERIS (NYSE:STE) CEO Sells $38,449.38 in Stock

October 9, 2025 | insidertrades.com

Robeco Institutional Asset Management B.V. Purchases 1,158 Shares of STERIS plc $STE

October 8, 2025 | marketbeat.com

Rep. April McClain Delaney Purchases Shares of STERIS plc (NYSE:STE)

October 8, 2025 | marketbeat.com

STERIS (NYSE:STE) Stock Acquired Rep. April McClain Delaney

October 8, 2025 | marketbeat.com

STERIS plc Stock (STE) Opinions on Institutional Investment Moves

October 7, 2025 | quiverquant.comQ

Fenimore Asset Management Inc Buys 9,556 Shares of STERIS plc $STE

October 6, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GMED, DXCM, STE, and PODD Company Descriptions

DexCom NASDAQ:DXCM

$65.33 -0.88 (-1.33%)

As of 03:56 PM Eastern

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Globus Medical NYSE:GMED

$58.38 +0.29 (+0.50%)

As of 03:56 PM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insulet NASDAQ:PODD

$312.35 -5.95 (-1.87%)

As of 03:56 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS NYSE:STE

$236.42 -1.39 (-0.58%)

As of 03:56 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GMED, DXCM, STE, and PODD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GMED, DXCM, STE, and PODD Earnings

Compare Dividends

Latest GMED, DXCM, STE, and PODD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GMED, DXCM, STE, and PODD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

GMED, DXCM, STE, and PODD Company Descriptions

DexCom NASDAQ:DXCM

Globus Medical NYSE:GMED

Insulet NASDAQ:PODD

STERIS NYSE:STE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools